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STABILITY
Stability of Pharmacotherapeutic and Nutritional Compounds
Lakshmi Putcha Ph.D. and Scott M. Smith, Ph.D. 
Description:  Analysis of returned foods and drugs from ISS has indicated that some 
pharmaceuticals and vitamins are significantly degraded in 
space, and this may harm the health of crews on future
exploration missions. Stability will identify those
pharmaceuticals, vitamins, and amino acids that degrade in
space and collect controlled data on the timecourse of 
degradation of in space. The data gathered from Stability
will support the development of mathematical models to
predict shelf life of products for long duration exploration missions and be the 
foundation for future efforts for alternative formulation, packaging and shielding for 
medicines and foods to ensure the integrity and quality of products used by crew during 
exploration missions. 
BDC:  Identical kits stored on the ground as controls
On-Orbit Ops:  Four identical sample kits (containing pharmaceuticals, food,  dosimeter 
and a temperature sensor) were delivered to ISS during the STS-121 mission, July, 2006. 
The final kit was returned on STS-126 in November 2008 after 29 months in a 
microgravity environment and sample analysis is in progress. 2
Description: The PFE-OUM was a collaborative effort between NASA and ESA for the  
evaluation of crew aerobic capacity. The Pulmonary Function System upgraded 
hardware  provided the ability to directly measure oxygen consumption with the crew 
breathing through a mouthpiece in the performance of the routine PFE evaluation. 
Subjects Required: 7 ISS crewmembers
BDC:
Preflight, subjects will undergo a peak cycle test and a 
submaximal cycle test . Postflight, the subjects will perform
the nominal submaximal cycle test at R+5/7 and R+30 
days.
On-Orbit Ops: In-flight, subjects will setup and calibrate the 
PFE-OUM hardware and perform the exercise protocol on the 
CEVIS. Blood pressure  and ECG were measured throughout  the protocol continuously.
The initial in-flight PFE-OUM session was performed at flight day 14 and then every 30 
days after throughout the mission.
PFE-OUM 
Periodic Fitness Evaluation with Oxygen Uptake Measurement
Sean K. Roden M.D., JSC and Filippo Castrucci, M.D., ESA
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NUTRITION
Nutritional Status Assessment
Scott M. Smith, Ph.D.
Description: Assessment of space flight impact on crew nutritional status, bone health, 
and rehabilitation. The data collected will allow for the evaluation of the efficacy 
of current and potential countermeasures.
Subjects Required:  12 Long
BDC: Void-by-void 48 hour urine samples, fasting 
blood samples, a sublingual swab for tissue mineral 
testing, and exercise logs will be collected two times 
preflight and two times postflight .  An additional 
blood draw at L-10 will also be performed and two 
DEXA scans (one preflight and one postflight) will be 
obtained.
On-Orbit Ops: Blood and void-by-void 24 hour urine 
samples are collected five times in-flight (at FD15, 30, 
60, 120, and 180). In-flight body mass, dietary and 
exercise data are obtained from Space Medicine.
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Description: Perform tests to characterize in-flight changes in cardiovascular and 
cerebrovascular function that might preclude crewmembers from being able to 
overcome postflight orthostatic intolerance. 
Subjects Required: 6 ISS crewmembers
BDC: Recordings of heart rate and arterial blood pressure during 5-minutes of quiet, 
resting conditions and during 5-minutes of timed breathing. 24-hour  recordings of heart 
rate and physical activity at L-30 and one session between R+1 & R+5
Lower Body Negative Pressure (LBNP) Protocol at L-30 
within 24 hours, ideally prior to subject assuming upright 
position
On-Orbit Ops: One session early (between FD14 and 21) and
one session late in the increment.
CCISS
Cardiovascular and Cerebrovascular Control on Return from ISS
Richard Hughson, Ph.D./University of Waterloo, Canada
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Description: The success & effectiveness of manned 
spaceflight depends on the ability of crewmembers to 
maintain a high level of cognitive performance & vigilance. 
Astronauts, however, commonly experience sleep disruption
& may experience misalignment of circadian phase during 
spaceflight. Both of these conditions are associated with
insomnia, &and impairment of alertness & cognitive 
performance. 
Subjects Required: 20 Long, All  Shuttle
BDC:  Actiwatch recording, daily sleep logs, and a debrief will be performed preflight 
and postflight. 
On-Orbit Ops: Crewmembers will don Actiwatches as soon as possible after launch and 
wear the watches continuously throughout the mission.  Crewmembers will complete an 
electronic Sleep log for 7 consecutive days during at least three weeks on-orbit. 
SLEEP
Sleep-Wake Actigraphy & Light Exposure during Space Flight
Charles Czeisler, Ph.D., M.D.
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BRASLET
Validation of On-Orbit Methodology for the Assessment of Cardiac Function and Changes 
in the Circulating Volume Using Ultrasound and Braslet-M Occlusion Cuffs
J. Michael Duncan, M.D., JSC  and Valery Bogomolov, M.D. Ph.D., IBMP
Description: Evaluation of ultrasound methodology for the measurement of 
cardiovascular volume and function in microgravity. This study combines the use of 
Braslet-M devices as a means to acutely alter volume distribution while focused 
ultrasound measurement techniques are developed. The successful development of this 
measurement technique will provide a means of measuring cardiovascular function, 
methodologies that will result in significant new capability and knowledge enhancing 
areas of operational space medicine including clinical management of volume shifts 
induced by altered gravity, clinical diagnostic ultrasound in space flight, and 
telemedicine.
Subjects Required:  5 ISS crewmembers, 10 paired scans
BDC:  No preflight activities
On-Orbit Ops: Two in-flight sessions per crewmember
7
Description: Immune dysregulation has been demonstrated to occur during spaceflight, 
This investigation assesses the clinical risks resulting from the adverse effects of 
spaceflight on the human immune system and will validate a flight-compatible immune 
monitoring strategy. 
Subjects Required:  17 ISS and 17 Shuttle crewmembers
BDC: Short-duration crewmembers provide blood, urine, and 
saliva samples (both liquid and dry book) at L-180, L-10, R+0, 
and R+14.  Long-duration crewmembers provide the same 
samples at L-180, L-45, R+0, and R+30.
On-Orbit Ops: Short-duration crewmembers take liquid saliva samples every other day 
throughout the flight and dry book saliva samples on FD2 and R-1.  A blood sample is 
also required the day before landing. Long-duration crewmembers provide four liquid 
saliva samples (collected every other day), one dry book saliva sample, and one blood 
sample at three points during their mission (early, middle, and late increment).  
INTEGRATED IMMUNE
Validation of Procedures for Monitoring Crewmember Immune Function
Clarence Sams, Ph.D
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Description: As spaceflight mission duration increases, the potential development of 
infectious illness in crewmembers during flight also increases. This is especially true with 
latent viruses and infections caused by these viruses are not mitigated by a quarantine 
period. An example of a latent infection is Epstein-Barr virus (EBV), of which 
approximately 90% of the adult population is infected. Stress and other acute/chronic 
events reactivate this virus from latency, which results in increased viral replication. 
This investigation will assess the immune system function using blood and urine samples 
collected before and after spaceflight. 
Subjects Required: 17 ISS crewmembers
BDC: Blood and 24-hour urine samples will be collected
preflight (L-180, L-44, L-10 and L-3 or 2 days) and after
landing (R+0, R+3, R+14 and R+180). 
On-Orbit Ops: None
EPSTEIN-BARR
Space Flight-Induced Reactivation of Latent Epstein-Barr Virus
Raymond Stowe, Ph.D.
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Description: Isolation and confinement on long duration space missions can impact 
crew health and morale which are important factors that can affect mission success. 
This study converts behavioral and human factors data contained in journal entries 
into quantitative data on the importance of different behavioral issues in long 
duration crews. By studying what crewmembers write about, it is hoped that we can 
identify those things that are most important to long duration crews. Findings will 
help sustain human performance during long duration space missions.
Subjects Required: 10 ISS  crewmembers
On-Orbit Ops: Crewmembers complete a journal 
(electronic or paper) with their thoughts and 
experiences for 15 minutes at least three times a week.  A questionnaire is 
also completed prior to launch, midway through the 
increment and several days following return to Earth.
JOURNALS
Behavioral Issues Associated with Isolation and Confinement
Jack Stuster, Ph.D., Anacapa Sciences, Incorporated, Santa Barbara, CA
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BISPHOSPHONATES
Bisphosphonates as a Countermeasure to Space Flight Induced 
Bone Loss
Adrian LeBlanc, Ph.D. and Toshio Matsumoto, M.D., Ph.D.
Description: Evaluation of bisphosphonates (either oral 
alendronate taken weekly throughout flight or IV zoledronic
acid administered once preflight), in conjunction with the 
routine in-flight exercise program, will protect ISS 
crewmembers from the regional decreases in bone mineral 
density documented on previous ISS flights. 
Subjects Required: 10 Long (5 alendronate, 5 zoledronic acid)
BDC: Preflight all subjects will complete DXA scans, peripheral (limb) QCT Scans , 
high resolution QCT scans, blood draws with 24-hr urine collections, and ultrasound 
imaging for assessment of renal stones.  Alendronate subjects will begin ingestion on 
L-17, L-10, & L-3.  Zoledronic Acid subjects will be administered the bisphosphonate
on L-45 .  At L-90, baseline health status will be obtained for all subjects prior to 
preflight dosing with bisphosphonates.  All subjects will begin Vitamin D and calcium 
supplementation as early as L-75.
On-Orbit Ops: Alendronate subjects will ingest a pill weekly and all subjects will take 
daily Vitamin D supplements.  Three 24 hr urine collection sessions (early, mid, and 
late-increment) will be performed by each subject . Diet and exercise logs will be 
obtained via data sharing. 11
REPOSITORY
NASA Biological Specimen Repository
Kathleen McMonigal, M.D.
Description:  Biological specimens provide a means for investigating 
the physiological responses to spaceflight.  Blood and urine are 
Collected before, during and after long-duration flight in order to 
establish an archive of human biological samples.  This archive, which ultimately 
will include samples from many different flights, will provide a 
potential population for future research activities and will serve as a 
valuable resource with which future investigators can validate clinical 
hypotheses, study spaceflight-related physiological changes, and 
investigate physiological markers.
Subjects Required: All USOS ISS crewmembers
BDC: Blood draw and 24 hr urine collection at L-45, R+3/7 and R+30
On-Orbit Ops: Blood draw (two tubes) and 24 hr void-by-void urine collection (one 
sample each void) at FD15, 30, 60, 120, and 180
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INTEGRATED CARDIOVASCULAR
Cardiac Atrophy and Diastolic Dysfunction During and After 
Long Duration Spaceflight
Description: Determine the magnitude of left and right 
Ventricular atrophy associated with long-duration spaceflight, 
and  relate this atrophy to measures of physical activity and cardiac work in-flight.
Determine the time course and pattern of progression of cardiac atrophy in-flight using 
cardiac ultrasound, determine the functional importance of cardiac atrophy for cardiac 
diastolic function and the regulation of stroke volume during gravitational transitions, 
and identify changes in ventricular conduction, depolarization and repolarization during 
and after long-duration spaceflight and relate these to changes in cardiac mass and 
morphology.
Subjects Required:  12 Long
Benjamin D. Levine, M.D. and Michael W. Bungo, M.D.
BDC: Resting and Exercise Echos with ECG, 48-hr BP/Holter/Activity Monitoring , 
Cardiac Function Test, MRI 
On-Orbit Ops: Resting Echo and Exercise Echo with 24-hr BP/Holter/Activity 
Monitoring
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Description: VO2max is the standard measure of aerobic capacity and is directly related 
to the physical working capacity of an individual. VO2max is related to the ability to 
perform an egress task while wearing a Launch and Escape space suit; therefore, 
decreased VO2max may represent a safety concern in the event of an emergency during 
space flight. This investigation  will  measure the  aerobic capacities of the crewmembers 
onboard the ISS. By understanding the changes in VO2max that occur within space 
flight, necessary adjustments can be made to EVA exercise countermeasures.
Subjects Required: 12 ISS crewmembers
BDC:  VO2max protocol at L-270, -60, -30, R+1, +10 and +30. 
Measures heart rate, blood pressure, volume of oxygen utilized,
volume of carbon dioxide produced, cardiac output, workload 
and perception of effort.
On-Orbit Ops:  VO2max protocol at FD15 and every 30 days 
VO2max
Evaluation of Maximal Oxygen Uptake and Submaximal Estimates of VO2max 
Before, During, and After Long Duration International Space Station Missions
Alan D. Moore, Jr., Ph.D., Johnson Space Center, Houston, TX 
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Investigation
Subjects Status
(through Increment 18)Required Completed
Stability 4 kits 4 kits Flight activities completed, final kit returned, sample and data analysis in progress
PFE-OUM 7 7
All  operations completed,  data analysis in 
progress
Nutrition 24 8
Crewmembers participating during Increment 19, 
Flight samples returned from Increment 16-18 and 
analysis in progress
CCISS 6 4
Crewmembers participating during Increment 19, 
planned completion of study expected after 
Increment 20/21
Sleep All Shuttle20 ISS
47 Shuttle
7 ISS
Study has successfully recruited ISS crewmembers 
for Increments 18-21
Braslet 10 scans 11 Investigation currently in progress during Increment 18
Integrated 
Immune
17 Shuttle
17 ISS
10 Shuttle
7 ISS
Study has successfully recruited ISS crewmembers 
for Increments 19-21, Shuttle phase of study 
expected to be completed in 2009
Epstein Barr 41 Shuttle17 ISS
36 Shuttle
18 ISS
Investigation is scheduled to fly its final subjects 
on both Shuttle and ISS missions in early 2009
Current NASA Human Research Program Flight Investigations
15
Ops Title
Subjects Status
(through Increment 18)Required Completed
Journals 10 11 Study completed following  Increment 18 postflight activities
Bisphophonate 10 0 Initial in-flight operations for this study scheduled to start during Increment 19
Repository All 7 Repository operations began with  Increment 16 Recruitment continues for all future ISS missions
Harness 5 0
New hardware has completed flight certification, 
initial in-flight operations are scheduled to begin 
with Increment 19
Spinal 23 0
Three crewmembers successfully recruited for 
participation during the STS-128 mission scheduled 
for August 2009
ICV 12 0
Successfully recruited the first three subjects for 
this investigation, flight operations are scheduled to 
begin with Increment 19 
Current NASA Human Research Program Flight Investigations
16
FUTURE FLIGHT 
INVESTIGATIONS
17
Physiological Factors Contributing to Post-flight Changes in Functional 
Performance  (FTT)
PI: Jacob Bloomberg, Ph.D.
An integrated set of functional and physiological tests to
determine how postflight changes in sensorimotor, 
cardiovascular, and muscle physiology impact functional 
performance.
Development of a New Instrumented Harness For Use In Spaceflight 
Exercise Countermeasures (Harness )
PI; Gail Perusek
Evaluation of a new treadmill harness design for comfort during
exercise, and measurement of the loads in the harness straps for 
d direct comparison with the current U.S. TVIS Harness. The 
research protocol is aimed at improving comfort, plus increasing 
consistent loading for crewmembers exercising on the ISS 
treadmill.
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Psychomotor Vigilance Test (Reaction Self Test )
PI: David Dinges, Ph.D.
The PVT Self Test provides astronauts with objective feedback on neurobehavioral 
changes in vigilant attention, psychomotor speed, state stability, and impulsivity. It will 
evaluate the extent to which PVT Self Test performance of astronauts is sensitive to 
fatigue from sleep loss and circadian disruption during the mission, fatigue from work 
intensity during the mission, decline of performance with time during the mission, and 
carry-over effects of medications for sleep on ISS.
Vertebral Compression Fracture
NASA Space Medicine
The study will collect data for the measurement of morphological changes to 
vertebral bodies for diagnosis of asymptomatic compression fractures in 
crewmembers after long-duration spaceflight and to 
evaluate morphological changes to vertebral bodies 
with longitudinal measures in the astronaut 
population to characterize changes over time. 
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Dietary Intake Can Predict and Protect Against Changes In Bone 
Metabolism During Space Flight And Recovery (Pro-K )
PI: Scott Smith, Ph.D.
This investigation will study the role of dietary intake patterns as one of the 
factors associated with bone mineral loss in space flight. The protocol is designed 
to evaluate the influence of acid and base precursors in the diet. 
This protocol will test the hypothesis that the 
ratio of acid precursors to base precursors 
(specifically animal protein and potassium, 
respectively) in the diet can predict changes in the loss 
of bone mineral during space flight and recovery. 
Human Factors Assessment of Vibration Effects on Visual Performance
(Visual  Performance )
PI: Katrina Holden, Ph.D.
Investigation to determine visual performance limits during operational vibration 
and g-loads on the Space Shuttle, specifically through the determination of 
minimum readable font size during ascent using planned Orion display formats. 
Urine Monitoring System (UMS)
PI: Daniel Feeback, Ph.D.
The ISS Urine Monitoring System is an automated void 
volume measurement and sample acquisition system for 
long term ISS science application. The UMS is capable of 
collecting and accurately measuring void volume , 
separating urine from air  and allowing acquisition of 
individual, uncontaminated urine samples.  Scheduled to 
launch on STS-130 (Feb, 2010)
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Integrated Resistance and Aerobic Training Study (IRAT )
PI: Lori Ploutz-Snyder, Ph.D.
Evaluation of the efficacy of a new integrated resistance and aerobic 
training (iRAT) program designed to minimize loss of muscle, bone and 
cardiovascular function using the ISS exercise hardware including the 
second generation treadmill and the ARED device. Highlights of the 
iRAT include an increase in the intensity and a reduction in the volume 
of resistance exercises, inclusion of very short, but high intensity 
interval-type aerobic exercises, and starting the exercise countermeasures
as early as possible in the flight, preferably in the first week. 
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Intravenous Fluids Generation for Exploration Missions (IVGEN )
PI: John McQuillen
IVGEN is a hardware technology development and demonstration effort to 
demonstrate the capability to purify water to the standards required for IV 
administration, then mix the water with salt crystals to produce normal saline.  This 
hardware is a prototype that will allow flight surgeons more options to treat ill or 
injured crew members both onboard ISS and during exploration missions.
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Spinal Elongation and its Effects on Seated Height in a Microgravity 
Environment
PI: Sadhaker Rajulu, Ph.D. 
Collection of spinal elongation induced seated and standing height data in 
crewmembers and provide information relating to the seated height
rate of change over time for astronauts subjected to microgravity. 
This seated height data in microgravity is considered necessary to 
correctly identify the seated height projections of the crew in the 
Orion configuration allowing for  proper positioning of the seats 
within the vehicle, maintaining adequate clearance for seat stroke in 
high acceleration impacts, providing proper fit in seats, proper 
placement of seats with respect to each other and the vehicle; and 
proper orientation to displays and controls. Additionally, data 
concerning the effects of spinal elongation on seated height would aid
in the design of suit components, habitation requirements and tool specifications. 
 Provide planning, integration, and implementation services for Human    
Research Program research tasks 
Maximize the utilization the ISS to assess the effects of long-duration 
spaceflight on human systems
 Define science  protocols as set of implementable functional requirements
to design operational scenarios
 Develop & certify hardware/software
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NASA-ISSMP
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 Develop & validate crew procedures and provide crew training
Monitor real-time ops and facilitate data transfer & remote PI interface
 Coordinate BDC schedules to facilitate pre-and post flight data 
collections  with International Partners
NASA-ISSMP
